September 5, 2025Open Access

Trends in Comorbidities and Medication Use Among Type 2 Diabetes Patients in Iran: A Gender-Specific Analysis (2021–2023)

View Full Paper

Ask AI

Bookmark

The prevalence of comorbidities like hypertension has increased among type 2 diabetes patients, indicating worsening health.
Medication trends reveal a decrease in metformin use and an increase in sulfonylureas, suggesting shifts in treatment approaches.
Glycemic control has worsened, evident from rising average HbA1c levels over the study period, highlighting the need for improved management.
Annual medication costs surged significantly, indicating financial burdens on patients and the need for cost-effective healthcare strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Quantitative analysis shows rising comorbidities and changing medication patterns in T2D patients, indicating gender-specific health needs.

Alijaniha et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Quantitative analysis shows rising comorbidities and changing medication patterns in T2D patients, indicating gender-specific health needs.